Stocks
Heron Therapeutics (HRTX) R&D US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 167.4 | 174.5 | 130.8 | 107.5 | 55.9 | 46.7 | |||
| Changes by years, y/y, % | +20% | +4% | -25% | -18% | -48% | -16.8% | |||
Heron Therapeutics. R&D, bln rub
Heron Therapeutics. R&D, changes, %
Heron Therapeutics. R&D, sum by quarters, bln rub
Heron Therapeutics (HRTX) R&D US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D, bln rub | 13.8 | 17.6 | 13.6 | 11.0 | 4.61 | 46.7 | ||
| Changes by years, y/y, % | -67% | -39% | -47% | -1% | -67% | |||
| Changes by quarters, q/q, % | +25% | +27% | -23% | -19% | -58% | |||
